<code id='9D48D41F5B'></code><style id='9D48D41F5B'></style>
    • <acronym id='9D48D41F5B'></acronym>
      <center id='9D48D41F5B'><center id='9D48D41F5B'><tfoot id='9D48D41F5B'></tfoot></center><abbr id='9D48D41F5B'><dir id='9D48D41F5B'><tfoot id='9D48D41F5B'></tfoot><noframes id='9D48D41F5B'>

    • <optgroup id='9D48D41F5B'><strike id='9D48D41F5B'><sup id='9D48D41F5B'></sup></strike><code id='9D48D41F5B'></code></optgroup>
        1. <b id='9D48D41F5B'><label id='9D48D41F5B'><select id='9D48D41F5B'><dt id='9D48D41F5B'><span id='9D48D41F5B'></span></dt></select></label></b><u id='9D48D41F5B'></u>
          <i id='9D48D41F5B'><strike id='9D48D41F5B'><tt id='9D48D41F5B'><pre id='9D48D41F5B'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:knowledge    Page View:218
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In